Stimulation of erythroid colony formation in vitro by erythropoietin immobilized on agarose-bound lectins.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 7299240)

Published in J Lab Clin Med on November 01, 1981

Authors

G D Roodman, J L Spivak, E D Zanjani

Articles by these authors

(truncated to the top 100)

AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood (1997) 7.84

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res (1995) 3.23

Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology (1988) 2.60

Detection of measles virus nucleocapsid transcripts in circulating blood cells from patients with Paget disease. J Bone Miner Res (1996) 2.33

Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N Engl J Med (1998) 2.29

KDR receptor: a key marker defining hematopoietic stem cells. Science (1999) 2.13

In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers. Blood (1999) 1.99

Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro. J Bone Miner Res (1989) 1.87

Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med (1996) 1.86

Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med (1984) 1.85

Polo-like kinase is a cell cycle-regulated kinase activated during mitosis. J Biol Chem (1995) 1.80

Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. J Clin Invest (1995) 1.79

Erythroid colony formation by polycythemia vera bone marrow in vitro. Dependence on erythropoietin. J Clin Invest (1977) 1.79

IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol (1990) 1.77

Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med (1990) 1.72

Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood (2000) 1.69

Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures. J Bone Miner Res (1986) 1.64

Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood (2001) 1.60

Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab (1996) 1.59

Involvement of hepcidin in the anemia of multiple myeloma. Clin Cancer Res (2008) 1.57

Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection. Infect Immun (1989) 1.54

Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures. Endocrinology (1990) 1.51

Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors. JAMA (1988) 1.51

Immunoablative high-dose cyclophosphamide without stem-cell rescue for refractory, severe autoimmune disease. Ann Intern Med (1998) 1.51

Formation of multinucleated cells that respond to osteotropic hormones in long term human bone marrow cultures. Endocrinology (1987) 1.46

Suppression of normal human hematopoiesis by cytomegalovirus in vitro. Exp Hematol (1993) 1.43

Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine (Baltimore) (1988) 1.41

Studies on the liver to kidney switch of erythropoietin production. J Clin Invest (1981) 1.41

Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures. J Clin Invest (1986) 1.41

A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates. J Bone Miner Res (1996) 1.40

Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. J Clin Invest (2001) 1.35

Suppression of erythroid-colony formation by lymphocytes from patients with aplastic anemia. N Engl J Med (1977) 1.33

Liver as the primary site of erythropoietin formation in the fetus. J Lab Clin Med (1977) 1.32

Characterization of the mouse tartrate-resistant acid phosphatase (TRAP) gene promoter. J Bone Miner Res (1995) 1.32

Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation. J Biol Chem (1991) 1.30

Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype. J Clin Invest (2000) 1.29

1,25-Dihydroxyvitamin D3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow. Proc Natl Acad Sci U S A (1985) 1.27

Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood (1989) 1.25

ADAM8: a novel osteoclast stimulating factor. J Bone Miner Res (2001) 1.24

Identification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells. J Cell Biol (1984) 1.22

Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci U S A (1988) 1.20

Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J Biol Chem (1999) 1.19

Cloning and identification of annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption. J Biol Chem (1994) 1.19

Atypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease. J Clin Invest (1990) 1.19

Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood (2000) 1.19

Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia. Arthritis Rheum (1988) 1.19

Role of endothelial cells in human hematopoiesis: modulation of mixed colony growth in vitro. Blood (1984) 1.18

Stimulation of mammalian erythropoiesis by 5beta-H steroid metabolites. Proc Natl Acad Sci U S A (1970) 1.17

Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone. Endocrinology (1992) 1.17

Transplantation of fetal hematopoietic stem cells in utero: the creation of hematopoietic chimeras. Science (1986) 1.16

Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells. J Immunol (1986) 1.14

Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures. J Clin Invest (1999) 1.14

Effect of phenylhydrazine-induced hemolytic anemia on nuclear RNA polymerase activity of the mouse spleen. Blood (1973) 1.14

Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. Blood (1996) 1.14

Studies of human pluripotential hemopoietic stem cells (CFU-GEMM) in vitro. Blood (1981) 1.13

Diamond-Blackfan syndrome: lymphocyte-mediated suppression of erythropoiesis. Science (1976) 1.13

Pellagra: an analysis of 18 patients and a review of the literature. Johns Hopkins Med J (1977) 1.11

Umbilical cord blood cells capable of engrafting in primary, secondary, and tertiary xenogeneic hosts are preserved after ex vivo culture in a noncontact system. Blood (2001) 1.10

Isolation and characterization of a cDNA clone encoding a novel peptide (OSF) that enhances osteoclast formation and bone resorption. J Cell Physiol (1998) 1.10

Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology (1989) 1.09

T cell chronic lymphocytic leukemia: presence in bone marrow and peripheral blood of cells that suppress erythropoiesis in vitro. Blood (1978) 1.09

Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone. J Clin Invest (2000) 1.09

1,25-Dihydroxyvitamin D3 hypersensitivity of osteoclast precursors from patients with Paget's disease. J Bone Miner Res (2000) 1.09

Bone marrow mononuclear cells from patients with Paget's disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence. J Clin Endocrinol Metab (1995) 1.09

Human llamas: adaptation to altitude in subjects with high hemoglobin oxygen affinity. J Clin Invest (1978) 1.08

Cell-cell interaction in erythropoiesis. Role of human monocytes. J Clin Invest (1978) 1.06

Hemoglobin switching in culture: evidence for a humoral factor that induces switching in adult and neonatal but not fetal erythroid cells. Proc Natl Acad Sci U S A (1982) 1.05

Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera. Blood (1999) 1.05

In-utero transplantation of fetal liver haemopoietic stem cells in monkeys. Lancet (1989) 1.05

Suppression of hematopoietic-progenitor-cell proliferation by ethanol and acetaldehyde. N Engl J Med (1982) 1.04

Clinical and molecular characterization of a re-established line of sheep exhibiting hemophilia A. J Thromb Haemost (2009) 1.04

Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype. J Bone Miner Res (1991) 1.04

Effects of parathyroid hormone (PTH)-related protein and PTH on osteoclasts and osteoclast precursors in vivo. Endocrinology (1995) 1.04

Genetic linkage of Paget disease of the bone to chromosome 18q. Am J Hum Genet (1997) 1.03

Osteoclast-like cells formed in long-term human bone marrow cultures express a similar surface phenotype as authentic osteoclasts. Lab Invest (1989) 1.03

CFU-GM-derived cells form osteoclasts at a very high efficiency. Biochem Biophys Res Commun (2000) 1.03

The mechanism of action of erythropoietin. Int J Cell Cloning (1986) 1.02

Control of osteoclast differentiation. Crit Rev Eukaryot Gene Expr (1998) 1.02

Androgen actions on erythropoiesis. Ann N Y Acad Sci (1968) 1.02

Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption. J Biol Chem (1999) 1.02

Erythropoietin production in cultures of goat renal glomeruli. Proc Natl Acad Sci U S A (1972) 1.01

Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes. J Clin Invest (1985) 1.01

Selective killing of leukemic cells by merocyanine 540-mediated photosensitization. Proc Natl Acad Sci U S A (1984) 1.01

Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero. Exp Hematol (1999) 1.00

Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures. J Clin Invest (1989) 1.00

Development of an in vivo model of human multiple myeloma bone disease. Blood (1996) 1.00

Measles virus nucleocapsid transcript expression is not restricted to the osteoclast lineage in patients with Paget's disease of bone. Exp Hematol (1999) 1.00

Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003). Blood (2001) 0.99

Anti-T-cell reagents for human bone marrow transplantation: ricin linked to three monoclonal antibodies. Science (1983) 0.99

Erythropoiesis in vitro. Role of calcium. J Clin Invest (1979) 0.99

Immortalization of osteoclast precursors by targeting Bcl -XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice. J Clin Invest (1998) 0.99

Nucleoside deaminase: an enzymatic marker for stress erythropoiesis in the mouse. J Clin Invest (1970) 0.98

Induction of stable prenatal tolerance to beta-galactosidase by in utero gene transfer into preimmune sheep fetuses. Blood (2001) 0.98

Sequential expression of phenotype markers for osteoclasts during differentiation of precursors for multinucleated cells formed in long-term human marrow cultures. Endocrinology (1990) 0.98

Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone. Am J Hum Genet (1998) 0.97

Adult haematopoietic cells transplanted to sheep fetuses continue to produce adult globins. Nature (1982) 0.97

In utero gene therapy: transfer and long-term expression of the bacterial neo(r) gene in sheep after direct injection of retroviral vectors into preimmune fetuses. Hum Gene Ther (1998) 0.97

Erythropoietin production in the fetal lamb. J Lab Clin Med (1969) 0.97

Lymphocytes suppressing both immunoglobulin production and erythroid differentiation in hypogammaglobulinaemia. Nature (1977) 0.97

Persistence of human multilineage, self-renewing lymphohematopoietic stem cells in chimeric sheep. Blood (1993) 0.96